Inhibitory effect of hepatocyte growth factor on metastasis of hepatocellular carcinoma in transgenic mice

Research Communications in Molecular Pathology and Pharmacology

Volumn 91, Issue 1, 1996, Pages 33-39

  Shiota, Goshi ^a   Kawasaki, Hironaka ^a   Nakamura, Toshikazu ^b   Schmidt, Emmett V ^c  

^a TOTTORI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GROWTH INHIBITION; LIVER CELL CARCINOMA; LIVER METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; HEPATOCYTE GROWTH FACTOR; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0029670654     PISSN: 00345164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cherardi, E. and Stoker, M. (1991). Hepatocyte growth factor-scatter factor: mitogen, motogen and met. Cancer Cells 3: 227-232.
2. Fujiwara, T., Sakagami, K., Matsuoka, J., Shiozaki, S., Uchida, S., Fujioka, K., Takada, Y. and Orita, K. (1990). Application of an interleukin 2 slow delivery system to the immunotherapy of established murine colon 26 adenocarcinoma liver metastases. Cancer Res. 50: 7003-7007.
3. Furlong, R.A., Takehara, T., Taylor, W.G., Nakamura, T. and Rubin, J.S. (1991). Comparison of biological and immunochemical properties indicate that scatter factor and hepatocyte growth factor are indistinguishable. J. Cell Sci. 100: 173-177.
4. Gohda, E., Tsubouchi, H., Nakayama, H., Sakiyama, O., Takahashi, K., Miyazaki, H., Hashimoto, S. and Daikuhara, Y. (1988). Purification and characterization of hepatocyte growth factor from plasma of a patient with hepatic failure. J. Clin. Invest. 81: 414-419.
5. Habu, S., Fukui, H., Shimamura, K., Kasai, M., Nagai, Y., Okumura, K. and Tamaoki, N. (1981). In vivo effects of anti-asialo GM1. J. Immunol. 127: 34-38.
6. Higashio, K., Shima, N., Goto, N., Itagaki, Y., Nago, M., Yasuda, H. and Morinaga, K. (1990). Identity of a tumor cytotoxic factor from fibroblasts and hepatocyte growth factor. Biochem. Biophys. Res. Commun. 170: 397-404.
7. Ishiki, Y., Ohnishi, H., Muto, Y., Matsumoto, K. and Nakamura, T. (1992). Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and for potent anti-hepatitis action in vivo. Hepatology 16: 1227-1235.
8. Kozlowski, J.M., Fidler, I.J., Campbell, D., Xu, Z., Kaighn, M.E. and Hart, I.R. (1984). Metastatic behavior of human tumor cell linesgrown in the nude mouse. Cancer Res. 44: 3522-3529.
9. Liu, M-L., Mars, W.N. and Michalopoulos, G.K. (1995). Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamine. Carcinogenesis 16: 841-843.
10. Montesano, R., Matsumoto, K., Nakamura, T. and Orci, L. (1991). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67: 901-908.
11. Nakamura, T., Nawa, K. and Ichihara, A. (1984). Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122: 1450-1459.
12. Nakamura, T., Teramoto, H. and Ichihara, A. (1986). Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culture. Proc. Natl. Acad. Sci. USA 83: 6489-6493. PAGES?
13. Paget, S. (1989). Distribution of secondary growths in cancer of the breast. Lancet I: 571-573.
14. Shiota, G., Kawasaki, H., Nakamura, T. and Schmidt, E.V. (1994b). Inhibitory effect of hepatocyte growth factor against FaO hepatocellular carcinoma cells may be associated with changes of intracellular signaling pathways mediated by protein kinase C. Res. Commun. Molec. Pathol. Pharmacol. 85: 271-278.
15. Shiota, G., Rhoads, D.R., Wang, T.C., Nakamura, T. and Schmidt, E.V. (1992). Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc. Natl. Acad. Sci. USA 89: 373-377.
16. Shiota, G., Wang, T.C., Nakamura, T. and Schmidt, E.V. (1994a). Hepatocyte growth factor in transgenic mice: Effects on hepatocyte growth, liver regeneration and gene expression. Hepatology 19: 962-972.
17. Tajima, H., Matsumoto, K. and Nakamura, T. (1991). Hepatocyte growth factor has anti-proliferative activity in various tumor cell lines. FEBS Lett. 291: 229-232.
18. Tepper, R.I., Pattengale, P.K. and Leder, P. (1989). Murine interleukin-4 displays potent anti-tumor effect in vivo. Cell 57: 503-512.
19. Weidner, K.M., Arakaki, N., Hartman, G., Vandekerckhove, J., Weingart, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, T., Daaikuhara, Y. and Birchneier, W. (1991). Evidence of the identity of human scatter factor and human hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 88: 7001-7005.
20. Zarnegar, R. and Michalopoulos, G. (1989). Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49: 3314-3320.